MEDYTOX INC.
21Patents
21Active
21Granted
51Portfolio score
Filing activity: May 28, 2008 → Apr 12, 2024 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8617568B2 | Pharmaceutical liquid composition of botulinum toxin with improved stability | Human Necessities | 24 | Active |
| US8920795B2 | Lyophilized preparation of botulinum toxin | Emerging Cross-Sectional Technologies | 19 | Active |
| US9220780B2 | Pharmaceutical liquid composition of botulinum toxin with improved stability | Human Necessities | 17 | Active |
| US8993268B2 | Method of producing Clostridium botulinum toxin using media containing plant-derived components and flexible closed container | Chemistry; Metallurgy | 14 | Active |
| US9198958B2 | Lyophilized preparation of botulinum toxin | Emerging Cross-Sectional Technologies | 13 | Active |
| US10293034B2 | Pharmaceutical liquid composition of botulinum toxin with improved stability and method of use | Human Necessities | 11 | Active |
| US9480731B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 10 | Active |
| US10143728B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 10 | Active |
| US11331598B2 | Method of isolating botulinum toxin from botulinum toxin-containing solution | Emerging Cross-Sectional Technologies | 4 | Active |
| US10105387B2 | Temperature sensitive adhesion prevention composition and use thereof | Human Necessities | 2 | Active |
| US10729700B2 | Methods and compositions of bile acids and salts for reduction of fat | Human Necessities | 1 | Active |
| US11517576B2 | Methods and compositions of bile acids and salts for reduction of fat | Human Necessities | 0 | Active |
| US12419836B2 | Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11198859B2 | Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same | Chemistry; Metallurgy | 0 | Active |
| US12274739B2 | Pharmaceutical liquid composition of botulinum toxin with improved stability | Human Necessities | 0 | Active |
| US11161872B2 | Methods for preparing bile acids | Emerging Cross-Sectional Technologies | 0 | Active |
| US11596673B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 0 | Active |
| US11590212B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 0 | Active |
| US11957741B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 0 | Active |
| US11801276B2 | Microorganism having ability to degrade ethanol and acetaldehyde, and composition and kit each including the same | Chemistry; Metallurgy | 0 | Active |
| US12377137B2 | Long lasting effect of new botulinum toxin formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.